Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brain-derived neurotrophic factor in patients with Huntington's disease.
Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-Lèvi AC, Tabrizi SJ, Di Donato S, Cattaneo E. Zuccato C, et al. Among authors: tarditi a. PLoS One. 2011;6(8):e22966. doi: 10.1371/journal.pone.0022966. Epub 2011 Aug 12. PLoS One. 2011. PMID: 21857974 Free PMC article.
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease.
Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L, Strand A, Tarditi A, Woodman B, Racchi M, Mariotti C, Di Donato S, Corsini A, Bates G, Pruss R, Olson JM, Sipione S, Tartari M, Cattaneo E. Valenza M, et al. Among authors: tarditi a. J Neurosci. 2005 Oct 26;25(43):9932-9. doi: 10.1523/JNEUROSCI.3355-05.2005. J Neurosci. 2005. PMID: 16251441 Free PMC article.
Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes.
Battista N, Bari M, Tarditi A, Mariotti C, Bachoud-Lévi AC, Zuccato C, Finazzi-Agrò A, Genitrini S, Peschanski M, Di Donato S, Cattaneo E, Maccarrone M. Battista N, et al. Among authors: tarditi a. Neurobiol Dis. 2007 Jul;27(1):108-16. doi: 10.1016/j.nbd.2007.04.012. Epub 2007 May 6. Neurobiol Dis. 2007. PMID: 17553686
Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages.
Varani K, Bachoud-Lévi AC, Mariotti C, Tarditi A, Abbracchio MP, Gasperi V, Borea PA, Dolbeau G, Gellera C, Solari A, Rosser A, Naji J, Handley O, Maccarrone M, Peschanski M, DiDonato S, Cattaneo E. Varani K, et al. Among authors: tarditi a. Neurobiol Dis. 2007 Jul;27(1):36-43. doi: 10.1016/j.nbd.2007.03.011. Epub 2007 Apr 5. Neurobiol Dis. 2007. PMID: 17512749
siRNA screen identifies QPCT as a druggable target for Huntington's disease.
Jimenez-Sanchez M, Lam W, Hannus M, Sönnichsen B, Imarisio S, Fleming A, Tarditi A, Menzies F, Dami TE, Xu C, Gonzalez-Couto E, Lazzeroni G, Heitz F, Diamanti D, Massai L, Satagopam VP, Marconi G, Caramelli C, Nencini A, Andreini M, Sardone GL, Caradonna NP, Porcari V, Scali C, Schneider R, Pollio G, O'Kane CJ, Caricasole A, Rubinsztein DC. Jimenez-Sanchez M, et al. Among authors: tarditi a. Nat Chem Biol. 2015 May;11(5):347-354. doi: 10.1038/nchembio.1790. Epub 2015 Apr 6. Nat Chem Biol. 2015. PMID: 25848931 Free PMC article.
Therapeutic targets for Alzheimer's disease.
Tarditi A, Caricasole A, Terstappen G. Tarditi A, et al. Expert Opin Ther Targets. 2009 May;13(5):551-67. doi: 10.1517/14728220902865614. Expert Opin Ther Targets. 2009. PMID: 19368497 Review.
15 results